Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Talis Biomedical Corporation (TLIS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.32-0.41 (-7.16%)
At close: 4:00PM EDT
5.35 +0.03 (+0.56%)
After hours: 06:51PM EDT
Advertisement

Talis Biomedical Corporation

230 Constitution Drive
Menlo Park, CA 94025
United States
650 433 3000
http://talis.bio

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees133

Key Executives

NameTitlePayExercisedYear Born
Ms. Kimberly J. PopovitsInterim Chief Exec. Officer12.82kN/A1959
Dr. Rustem F. Ismagilov Ph.D.Co-Founder, Chairman of Scientific Advisory Board & Director75kN/A1974
Mr. Douglas LiuChief Operating Officer255.62kN/A1962
Mr. Brian Coe M.B.A.Co-Founder & Advisor377.49kN/A1969
Mr. Robert KelleyChief Commercial Officer246.43kN/A1972
Mr. Liang Li Ph.D.Co-Founder and Director of Technology & StrategyN/AN/AN/A
Mr. J. Roger Moody Jr., M.B.A.Chief Financial OfficerN/AN/A1968
Mr. J. Roger MoodyChief Financial OfficerN/AN/A1968
Ms. Emily FaucetteSr. VP of Corp. Communications & Investor RelationsN/AN/AN/A
Dr. Karen E. Flick J.D., Ph.D.Chief of Staff & Sr. VP of LegalN/AN/A1969
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.

Corporate Governance

Talis Biomedical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement